10-Q · May 8, 2026
DCOY's Q1 2026 results reveal continued challenges with a net loss of $2.22 million, a significant increase from $1.71 million in Q1 2025, highlighting ongoing financial strain. Research and development expenses surged…
Earnings analysis · 10-Q
DCOY earnings analysis
Filed August 12, 2026 · Our reading of the company's report
The latest report
The supplied 10-Q text does not include the current-quarter income statement, balance sheet, cash flow statement or MD&A figures, so revenue, margin, cash-flow and segment trends cannot be quantified. The prior reported…
Read full summary
The supplied 10-Q text does not include the current-quarter income statement, balance sheet, cash flow statement or MD&A figures, so revenue, margin, cash-flow and segment trends cannot be quantified. The prior reported diluted EPS was negative $4.18 in Q1 2026, and no current-quarter EPS is disclosed in the supplied text. Sentiment remains bearish because the filing adds a potentially immediate Nasdaq delisting risk tied to a $5.0 million market-value threshold and 30 consecutive trading days below it.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
What stood out
-
Controls remained effective
Management concluded that disclosure controls and procedures were effective at the reasonable-assurance level as of June 30, 2026, and reported no significant change in internal control during the three months ended June 30, 2026.
-
No material legal proceedings
The company reported that it was not a party to any material legal proceedings as of August 12, 2026, although ordinary-course claims could still become material.
What to watch
-
Potential Nasdaq delisting
A Nasdaq rule approved on July 22, 2026 would require at least $5.0 million of market value of listed securities; below that threshold for 30 consecutive trading days could result in immediate delisting without a cure period. The company states its Common Stock is currently below the proposed $5.0 million threshold.
-
Dilution and financing pressure
If the $5.0 million Nasdaq market-value rule becomes effective, the company may need to issue securities or raise additional capital to regain compliance, potentially diluting existing shareholders and increasing costs.
-
Reduced liquidity if delisted
If delisted, the company may seek OTCQX quotation, but it states that OTCQX could involve significantly less trading volume, analyst coverage and investor interest, potentially reducing trading prices and capital-market access.
Management's outlook
No quantitative revenue or EPS outlook is provided in the supplied 10-Q text; numeric guidance fields are therefore null.
Earlier filings 2
10-K · April 30, 2026
DCOY's 10-K reveals a strategic focus on advancing its cancer immunotherapy pipeline through innovative computational modeling. Despite previous successes, faced with significant challenges, the firm projects a…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.